13F manager/TARO/

Charles Brandes (Brandes Investment Partners) exit Taro Pharmaceutical Industries Ltd.

Charles Brandes (Brandes Investment Partners) exit $-12.0M of disclosed value in Taro Pharmaceutical Industries Ltd..

Signal
Investor Move
Action
Exit
Capital
$-12.0M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence